Lupin Ltd. Hits Intraday Low Amid Price Pressure on 10 Aug 2026

52 minutes ago
share
Share Via
Lupin Ltd. experienced a notable decline today, touching an intraday low of Rs 2,236, reflecting a 5.25% drop as the stock faced significant price pressure and underperformed its sector peers in the Pharmaceuticals & Biotechnology industry.
Lupin Ltd. Hits Intraday Low Amid Price Pressure on 10 Aug 2026

Intraday Performance and Price Movement

The stock of Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, recorded a day change of -5.07%, underperforming the sector by 4.63%. The intraday low of Rs 2,236 marked a 5.25% decline from its previous close, signalling a sharp sell-off during the trading session. This drop extended the stock’s losing streak to two consecutive days, with a cumulative fall of 6.22% over this period.

Despite trading above its 200-day moving average, Lupin’s price remained below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating short- to medium-term downward momentum. This technical positioning suggests that recent trading activity has been weaker relative to its longer-term trend, contributing to the intraday pressure.

Market Context and Sector Comparison

While Lupin Ltd. struggled, the broader market exhibited resilience. The Sensex opened flat and gained marginally by 0.06%, trading at 78,548.80 points. Notably, several indices including the S&P BSE MidCap Select Index and NIFTY MNC hit new 52-week highs, reflecting strength in mid and small-cap segments. The Sensex has been on a three-week consecutive rise, gaining 3.27% in this timeframe, largely driven by mega-cap stocks.

In contrast, Lupin’s one-day performance of -5.01% starkly contrasted with the Sensex’s 0.07% gain. Over the past week, the stock declined 5.65% while the Sensex dipped marginally by 0.10%. The divergence widened over one month, with Lupin falling 10.18% against a 1.27% rise in the Sensex, and over three months, the stock dropped 5.72% while the benchmark advanced 1.59%. This relative underperformance highlights the immediate pressures facing Lupin amid a generally positive market backdrop.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Technical Indicators and Momentum Analysis

Technical signals for Lupin Ltd. present a mixed picture. On a weekly basis, the Moving Average Convergence Divergence (MACD) is mildly bearish, while the monthly MACD remains bullish. The Relative Strength Index (RSI) shows no clear signal weekly but is bearish monthly, suggesting some weakening momentum over the longer term.

Bollinger Bands indicate mild bullishness on both weekly and monthly charts, implying that price volatility remains contained within expected ranges. The Know Sure Thing (KST) indicator is bullish weekly but mildly bearish monthly, reflecting short-term strength amid longer-term caution. Dow Theory assessments show a bullish weekly trend but no clear monthly trend, while On-Balance Volume (OBV) is mildly bearish weekly and mildly bullish monthly, signalling mixed volume support.

Daily moving averages are mildly bullish, yet the stock’s current price below several key moving averages points to immediate resistance levels that have not been breached, contributing to the downward pressure observed today.

Performance Trends Over Various Timeframes

Examining Lupin’s performance over extended periods reveals a complex trend. The stock has delivered a 16.96% return over the past year, outperforming the Sensex which declined 1.63% in the same period. Year-to-date, Lupin has gained 6.15%, contrasting with the Sensex’s 7.82% loss. Over three years, Lupin’s return of 106.62% far exceeds the Sensex’s 19.59%, and over five years, Lupin’s 100.33% gain remains strong compared to the Sensex’s 44.00%.

However, over a decade, Lupin’s 45.10% return trails the Sensex’s 182.84%, indicating that while the stock has shown robust medium-term growth, it has lagged the broader market over the very long term. These trends contextualise the current price pressure as part of shorter-term fluctuations within a longer-term growth trajectory.

Curious about Lupin Ltd. from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Mojo Score and Rating Update

Lupin Ltd. currently holds a Mojo Score of 74.0, categorised as a Buy grade. This represents a downgrade from its previous Strong Buy rating, which was adjusted on 3 August 2026. The downgrade reflects a reassessment of the stock’s near-term outlook amid recent price weakness and technical signals. The mid-cap classification of Lupin further emphasises its sensitivity to market fluctuations compared to larger-cap peers.

The downgrade and current score align with the observed price pressure and underperformance relative to the sector and broader market indices, underscoring the challenges faced during today’s trading session.

Summary of Market Sentiment and Immediate Pressures

Today’s decline in Lupin Ltd. can be attributed to a combination of technical resistance, sector underperformance, and broader market dynamics. While the overall market and Sensex showed modest gains, Lupin’s stock price faced selling pressure, reflected in its intraday low and negative returns over multiple timeframes.

The stock’s position below key moving averages and mixed technical indicators suggest that immediate resistance levels are constraining upward momentum. The downgrade in Mojo Grade from Strong Buy to Buy further signals a cautious stance on the stock’s short-term prospects.

In contrast to the positive performance of mid and small-cap indices hitting new highs, Lupin’s relative weakness highlights sector-specific or stock-specific factors influencing investor behaviour and price action today.

Conclusion

Lupin Ltd.’s intraday low of Rs 2,236 and a 5.25% decline today reflect significant price pressure amid a generally positive market environment. The stock’s underperformance relative to the Sensex and its sector peers, combined with technical indicators and a recent rating downgrade, illustrate the immediate challenges it faces. Investors and market participants will likely monitor these developments closely as Lupin navigates this phase of price consolidation and sector dynamics.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News